Citius Pharmaceuticals, Inc.: Diferență între versiuni

Pagina dedicata companiei Citius Pharmaceuticals, Inc. listata cu simbolul US.CTXR

Descriere companie

Citius Pharmaceuticals Inc. (www.citiuspharma.com) is a specialty pharmaceutical company. The Company is focused on development of critical care products, such as anti-infective products in adjunct cancer care, prescription products and stem cell therapy. The Company has three products: Mino-Lok, CITI-002 (halobetasol-lidocaine formulation) and CITI-101 (Mino-Wrap). Mino-Lok product is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections (CRBSIs). CITI-002 helps to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids. Mino-Wrap product (CITI-101) is a malleable, bio-absorbable film impregnated with minocycline and rifampin. It is designed to reduce infections associated with the use of breast tissue expanders (TE) used in breast reconstruction surgeries following mastectomies.

Grafic actiuni companie

Ultimele stiri despre Citius Pharmaceuticals, Inc. (US.CTXR)

• Citius Pharmaceuticals, Inc.